Expertise

 

Resource


Reversal of $200-million drug patent verdict offers hard lessons for tech collaborators

A recent U.S. District Court decision offers lessons to collaborative companies about the pitfalls that can arise when sharing sensitive technology.
What should entrepreneurs and collaborators know?